Skip to content

A clinical study to observe the effect of two drugs, Mahavasakadi Kwatha and Chandrakala Rasa along with Darvyadi Anjana in patients with Non Proliferative Diabetic Retinopathy

A CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF CHANDRAKALA RASA IN THE MANAGEMENT OF NON-PROLIFERATIVE DIABETIC RETINOPATHY

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078689
Enrollment
120
Registered
2024-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes

Interventions

None listed

Sponsors

Dr Sushobhitha M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with minimal visual acuity of 6/36 Patients having minimum history of DM for 10 years Patients with good glycemic control HbA1C less than 7

Exclusion criteria

Exclusion criteria: Patients having proliferative diabetic retinopathy changes Patients with history of visual impairments like glaucoma and matured lenticular opacity changes Patients with history of Pathological myopia and other degenerative conditions Patients with other systemic disorders which may interfere with the course of study

Design outcomes

Primary

MeasureTime frame
Improvement in subjective and objective parametersTimepoint: 7weeks

Secondary

MeasureTime frame
Sustained effect of treatment on subjective and objective parameters Effect on blood sugar levelTimepoint: 3 year

Countries

India

Contacts

Public ContactDr Syed Munawar Pasha

Government Ayurveda medical college, Bengaluru

smpasha78@gmail.com9886593932

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026